Teva Pharm says FDA to decide on migraine drug on Sept 16
May 23, 2018 at 08:34 AM EDT
JERUSALEM, May 23 (Reuters) - Israeli drugmaker Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as early as mid-September, after an initial delay.
